Search research articles
Contact Us
Filters
Showing results (171-180 of 940) with videos related to
Page
of 94
Sort By:
Cancer Research
|
May 16, 2000
Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models
H Miyake, C Nelson, P S Rennie, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
February 10, 1999
Prostate cancer: 9. Treatment of advanced disease
M E Gleave, N Bruchovsky, M J Moore, et al.
The Cochrane Database of Systematic Reviews
|
November 30, 2018
Piperonyl butoxide (PBO) combined with pyrethroids in insecticide-treated nets to prevent malaria in Africa
Katherine Gleave, Natalie Lissenden, Marty Richardson, et al.
Urologic Oncology
|
June 20, 2026
Automating standardization of prostate cancer biopsy and histopathology reports with privacy-preserving local large language models
Rohit Malyala, Takeshi Namekawa, Anna Black, et al.
Oncology Reports
|
April 6, 2005
Enhanced radiosensitivity by inhibition of the anti-apoptotic gene clusterin using antisense oligodeoxynucleotide in a human bladder cancer model
Kazuki Yamanaka, Martin Gleave, Mototsugu Muramaki, et al.
The British Journal of Surgery
|
December 1, 1996
Clinical significance of the tumour capsule in the treatment of parotid pleomorphic adenomas
M McGurk, A Renehan, E N Gleave, et al.
Endocrinology
|
June 1, 2000
Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway
H Miyake, C Nelson, P S Rennie, et al.
Der Urologe. Ausg. A
|
September 1, 1995
[Theoretical considerations and initial clinical results of intermittent hormone treatment of patients with advanced prostatic carcinoma]
N Bruchovsky, S L Goldenberg, P S Rennie, et al.
Cancer Chemotherapy and Pharmacology
|
August 19, 2007
The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors
Jianjun Lu, John K Jackson, Martin E Gleave, et al.
Journal of Cellular Physiology
|
February 3, 2005
Antisense clusterin oligodeoxynucleotides increase the response of HER-2 gene amplified breast cancer cells to Trastuzumab
Annamaria Biroccio, Carmen D'Angelo, Burkhard Jansen, et al.
Page
of 94
Search research articles
Search
Showing results (171-180 of 940) with videos related to
Sort By:
Page
of 94
Cancer Research
|
May 16, 2000
Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models
H Miyake, C Nelson, P S Rennie, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
February 10, 1999
Prostate cancer: 9. Treatment of advanced disease
M E Gleave, N Bruchovsky, M J Moore, et al.
The Cochrane Database of Systematic Reviews
|
November 30, 2018
Piperonyl butoxide (PBO) combined with pyrethroids in insecticide-treated nets to prevent malaria in Africa
Katherine Gleave, Natalie Lissenden, Marty Richardson, et al.
Urologic Oncology
|
June 20, 2026
Automating standardization of prostate cancer biopsy and histopathology reports with privacy-preserving local large language models
Rohit Malyala, Takeshi Namekawa, Anna Black, et al.
Oncology Reports
|
April 6, 2005
Enhanced radiosensitivity by inhibition of the anti-apoptotic gene clusterin using antisense oligodeoxynucleotide in a human bladder cancer model
Kazuki Yamanaka, Martin Gleave, Mototsugu Muramaki, et al.
The British Journal of Surgery
|
December 1, 1996
Clinical significance of the tumour capsule in the treatment of parotid pleomorphic adenomas
M McGurk, A Renehan, E N Gleave, et al.
Endocrinology
|
June 1, 2000
Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway
H Miyake, C Nelson, P S Rennie, et al.
Der Urologe. Ausg. A
|
September 1, 1995
[Theoretical considerations and initial clinical results of intermittent hormone treatment of patients with advanced prostatic carcinoma]
N Bruchovsky, S L Goldenberg, P S Rennie, et al.
Cancer Chemotherapy and Pharmacology
|
August 19, 2007
The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors
Jianjun Lu, John K Jackson, Martin E Gleave, et al.
Journal of Cellular Physiology
|
February 3, 2005
Antisense clusterin oligodeoxynucleotides increase the response of HER-2 gene amplified breast cancer cells to Trastuzumab
Annamaria Biroccio, Carmen D'Angelo, Burkhard Jansen, et al.
Page
of 94